Non classé

IMPROVE-2 Trial: A New Treatment Approach for mCRC

The IMPROVE-2 trial is exploring a new way to treat metastatic colorectal cancer (mCRC) by comparing intermittent versus continuous use of Panitumu...

Read

READI Project Officially Launched: Pioneering Diversity and Inclusion in Clinical Studies

On January 16, 2025, the groundbreaking READI project—Research in Europe and Diversity Inclusion—officially launched. Funded by the Horizon Eur...

Read

ESMO Expands Globally with New Patient Advocates Working Group

ESMO is proud to announce the launch of its newly globalised Patient Advocates Working Group (PAWG), now led by Zorana Maravic as Chair. This miles...

Read

Empowering Cancer Patients: SmartCARE Showcase Event

The SmartCARE Showcase Event, organised by the European Cancer Organisation, brought together patient advocates, clinicians, and IT experts to intr...

Read

Advancing Rare Cancer Care: DiCE at the EURACAN Board Meeting

On the 7th and the 8th of November, Laura Urena from Digestive Cancers Europe (DiCE) and a member of EURACAN Patient Advocacy Group (EPAG), partici...

Read

United Against Cancer: Driving Policy and Advocacy at the European Cancer Summit 2024

This event explored innovative strategies to address inequalities and advance cancer care across Europe, aligning closely with Digestive Cancers Eu...

Read

Tevimbra (tislelizumab) Receives New European Recommendations for Oesophageal and Gastric Cancer

Tevimbra (tislelizumab) receives CHMP recommendations for treating PD-L1-positive oesophageal squamous cell carcinoma and gastric/gastroesophageal ...

Read

Ponsegromab: A New Hope for Cancer Cachexia Treatment

Cancer cachexia, a severe wasting syndrome often experienced by patients with advanced cancer, leads to substantial weight loss, muscle wasting, an...

Read

Empowering Patient Voices at the National Congress of Medical Oncology

I am thrilled to share my experience of being invited to speak at the National Congress of Medical Oncology opening ceremony. This prestigious even...

Read

Zorana Maravic, DiCE CEO, Co-Chairs Global Effort for Medicine Accessibility

In an inspiring move toward global healthcare improvement, Zorana Maravic, CEO of Digestive Cancers Europe (DiCE), took centre stage as co-chair of...

Read

In order to facilitate the use of our website, we use cookies.

Please confirm if you accept our tracking cookies. When declining the cookies, you can continue visiting the website without sending data to third party services. Read our complete cookie statement here.